Detection of GPC1+ circulating TEXs in the serum of patients with pancreatic cancer distinguished healthy donors and patients with a benign pancreatic disease from patients with early- and late-stage pancreatic cancer with high sensitivity and specificity. This evidence concerns the gene GPC1 and pancreatic neoplasm.